What is Teprotumumab: Uses, Dosage, Side Effects and More

Teprotumumab is a specialized intravenous medication designed to treat thyroid eye disease, a condition that causes inflammation and swelling around the eyes. This targeted therapy works by blocking specific inflammatory pathways that contribute to the painful symptoms and vision changes many people experience with this autoimmune condition.

If you or someone you care about has been diagnosed with thyroid eye disease, you might feel overwhelmed by the treatment options. Understanding how teprotumumab works can help you feel more confident about your healthcare decisions and what to expect during treatment.

What is Teprotumumab?

Teprotumumab is a monoclonal antibody that targets insulin-like growth factor-1 receptor (IGF-1R). This medication helps reduce the inflammation and tissue changes that occur in thyroid eye disease, particularly the swelling and scarring behind the eyes.

The medication belongs to a class of drugs called biologics, which are made from living cells rather than chemicals. Think of it as a very specific key designed to unlock and block the inflammatory processes causing your eye symptoms.

Unlike traditional steroids or other anti-inflammatory medications, teprotumumab specifically targets the root cause of thyroid eye disease. This precision approach often leads to better outcomes with fewer widespread side effects throughout your body.

What is Teprotumumab Used For?

Teprotumumab is primarily used to treat thyroid eye disease, also known as Graves' ophthalmopathy or thyroid-associated orbitopathy. This condition affects the muscles, fat, and tissues around your eyes, causing them to become inflamed and swollen.

You might be a candidate for this treatment if you experience bulging eyes, double vision, dry eyes, or difficulty closing your eyelids completely. Many people also develop pain, redness, and a feeling of pressure behind their eyes that can significantly impact daily activities.

The medication is particularly helpful for people in the active inflammatory phase of thyroid eye disease. Your doctor will likely recommend it if other treatments haven't provided adequate relief or if your symptoms are progressing rapidly.

How Does Teprotumumab Work?

Teprotumumab works by blocking the IGF-1 receptor, which plays a key role in the inflammatory process behind thyroid eye disease. When this receptor is blocked, it helps prevent the excessive production of substances that cause tissue swelling and scarring around your eyes.

This is considered a strong and targeted medication because it addresses the specific biological pathway causing your symptoms. Rather than simply reducing inflammation broadly, it focuses on the exact mechanism driving thyroid eye disease progression.

The medication helps reduce the accumulation of glycosaminoglycans, which are substances that build up in the eye tissues and contribute to swelling. By controlling this buildup, teprotumumab can help improve eye movement, reduce bulging, and restore more normal eye function over time.

How Should I Take Teprotumumab?

Teprotumumab is given as an intravenous infusion directly into your bloodstream through a vein, typically in your arm. You cannot take this medication by mouth or inject it yourself at home.

Each infusion session takes place in a healthcare setting, usually lasting about 60 to 90 minutes. During this time, healthcare professionals will monitor you closely to ensure you're responding well to the treatment and watch for any immediate reactions.

You don't need to fast before your infusion, but it's helpful to stay well-hydrated by drinking plenty of water beforehand. Some people find it comfortable to bring a book, tablet, or music to help pass the time during the infusion.

Your healthcare team will likely give you medications before the infusion to help prevent allergic reactions. This might include antihistamines or corticosteroids, which are standard precautions for this type of treatment.

How Long Should I Take Teprotumumab For?

The standard treatment course for teprotumumab involves eight infusions given over approximately 21 weeks. You'll typically receive one infusion every three weeks, allowing your body time to respond between treatments.

Most people begin to notice improvements in their symptoms after the first few infusions, though the full benefits may take several months to become apparent. Your doctor will monitor your progress closely throughout the treatment period.

After completing the initial course, you likely won't need ongoing infusions unless your symptoms return or worsen significantly. Many people experience sustained improvement for months or even years after finishing treatment.

Your healthcare provider will schedule regular follow-up appointments to assess how well the medication is working and whether any adjustments to your treatment plan are needed.

What Are the Side Effects of Teprotumumab?

Like all medications, teprotumumab can cause side effects, though not everyone experiences them. Understanding what to expect can help you feel more prepared and know when to contact your healthcare team.

The most common side effects tend to be manageable and often improve as your body adjusts to the medication:

• Muscle spasms or cramps, particularly in your legs
• Nausea or upset stomach
• Hair loss or thinning, which is usually temporary
• Diarrhea or changes in bowel habits
• Fatigue or feeling more tired than usual
• Dry skin or changes in skin texture
• Headaches
• Taste changes or altered sense of taste

These common side effects are generally mild to moderate and don't typically require stopping the medication. Your healthcare team can often suggest ways to manage these symptoms effectively.

Some people may experience more serious side effects that require immediate medical attention, though these are less common:

• Severe allergic reactions during or after infusion
• Significant changes in blood sugar levels
• Severe muscle weakness or pain
• Difficulty breathing or chest tightness
• Severe skin reactions or rash
• Signs of infection such as fever, chills, or persistent sore throat

Very rarely, some people may develop inflammatory bowel disease or experience flare-ups of existing autoimmune conditions. Your doctor will monitor you carefully for these possibilities throughout your treatment.

Who Should Not Take Teprotumumab?

Teprotumumab isn't suitable for everyone, and your doctor will carefully evaluate whether it's the right choice for your specific situation. Certain medical conditions or circumstances may make this treatment inappropriate or require special precautions.

You should not receive teprotumumab if you have a known allergy to the medication or any of its components. Your healthcare provider will review your allergy history thoroughly before starting treatment.

People with active inflammatory bowel disease, such as Crohn's disease or ulcerative colitis, may need to avoid this medication or require very careful monitoring. The medication can potentially worsen these conditions in some individuals.

If you're pregnant or planning to become pregnant, teprotumumab is not recommended as it may harm the developing baby. Women of childbearing age should use effective contraception during treatment and for several months afterward.

Your doctor will also consider other factors such as your overall health, current medications, and any history of autoimmune diseases before recommending teprotumumab.

Teprotumumab Brand Name

Teprotumumab is sold under the brand name Tepezza. This is currently the only FDA-approved brand available in the United States for treating thyroid eye disease.

When discussing your treatment with healthcare providers or insurance companies, you might hear both names used interchangeably. Tepezza is the commercial name you'll see on your medication labels and insurance documentation.

The generic name "teprotumumab-trbw" includes the suffix that identifies the specific formulation and manufacturing process. This helps distinguish it from other potential versions that might be developed in the future.

Teprotumumab Alternatives

While teprotumumab is the first and currently only FDA-approved medication specifically for thyroid eye disease, your doctor might consider other treatment options depending on your individual situation and symptoms.

Corticosteroids, such as prednisone, are often used to reduce inflammation in thyroid eye disease, though they come with their own set of side effects and aren't as targeted as teprotumumab. These medications can be effective for some people but may not provide the same level of improvement.

For severe cases, orbital radiotherapy might be considered, though this approach is less commonly used today. Some people benefit from selenium supplements, particularly in the early stages of mild thyroid eye disease.

Surgical options, such as orbital decompression or eye muscle surgery, might be recommended for people who don't respond adequately to medical treatments or who have permanent changes that affect their vision or quality of life.

Is Teprotumumab Better Than Steroids?

Teprotumumab offers several advantages over traditional corticosteroids for treating thyroid eye disease. The medication is specifically designed to target the underlying cause of the condition rather than just reducing inflammation broadly.

Clinical studies have shown that teprotumumab can be more effective than steroids at reducing eye bulging and improving double vision. Many people experience more significant and lasting improvements with teprotumumab compared to steroid treatments.

Steroids can cause numerous side effects throughout the body, including weight gain, mood changes, elevated blood sugar, and bone thinning with long-term use. Teprotumumab's targeted approach often results in fewer systemic side effects.

However, steroids are less expensive and more widely available than teprotumumab. Your doctor will help you weigh the benefits and risks of each option based on your specific circumstances, insurance coverage, and treatment goals.